Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
analytical, artificial, biographical, Biopharma, biopharmaceutical, cardiac, CFR, companion, comparison, Cosmetic, decision, Digestive, displaying, enforcement, expedite, faster, feedback, fuller, Gastrointestinal, ISSN, iv, journal, LDT, leadership, learning, linked, machine, medRxiv, module, posted, preprint, proxy, ready, refinancing, restructuring, safety, SaMD, Shaun, solution, step, subpart, surveillance, System, threshold, tightly, triage, unlimited, validation, validity
Removed:
accelerated, Commitment, efficiently, involving
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view